{
  "nct_id": "NCT64963456",
  "indication": "Parkinson's Disease",
  "phase": "Phase 1",
  "sample_size": 73,
  "duration_weeks": 9,
  "dropout_rate": 0.02,
  "blinding": "open-label",
  "control_arm": "placebo",
  "primary_endpoints": [
    "ON time without dyskinesia"
  ],
  "secondary_endpoints": [
    "UPDRS score improvement",
    "OFF time reduction"
  ],
  "outcome_summary": "Study terminated early due to futility",
  "success": 0,
  "failure_reason": "Unexpected safety signal",
  "start_date": "2023-01-26",
  "completion_date": "2023-03-30"
}